Business Insider

Sequana Medical Reports Strong US Commercial Progress with Five Centers Completing alfapump® System Implants Since Launch

Leading US liver transplant center completes its first two implantations Mount Sinai Hospital and University of Pennsylvania also complete multiple implantations Dartmouth Hitchcock Medical Center and ...
Fox2Now St. Louis

Press release: Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis The Company will be hosting a further webcast with key opinion ...
Business Insider

Sequana Medical’s alfapump® System Featured in Presentation at 2025 Portal Intervention Symposium

, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Dr. Rahul Patel of Icahn School of Medicine at Mount Sinai presented “alfapump®: Totally Implantable Peritoneal Drain Pump with Urinary Bladder Drainage” Ghent, ...
ascopubs.org

Continuous low-flow ascites drainage and sequential non-invasive tumor-cell sampling through the urinary bladder via the alfa-pump closed system in platinum-resistant ovarian ...

Validation of urinary HE4 as a biomarker for ovarian cancer. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text component.